{
    "id": 1896,
    "fullName": "KRAS Q61L",
    "impact": "missense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "KRAS Q61L is a hotspot mutation that lies within a GTP-binding region of the Kras protein (UniProt.org). Q61L results in increased activation of ERK and is transforming in cell culture (PMID: 26854029) and therefore, is predicted to result in a loss of Kras protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 10250,
                    "pubMedId": 26854029,
                    "title": "KRAS insertion mutations are oncogenic and exhibit distinct functional properties.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26854029"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3845,
        "geneSymbol": "KRAS",
        "terms": [
            "KRAS",
            "'C-K-RAS",
            "C-K-RAS",
            "c-Ki-ras",
            "c-Ki-ras2",
            "CFC2",
            "K-Ras",
            "K-Ras 2",
            "K-RAS2A",
            "K-RAS2B",
            "K-RAS4A",
            "K-RAS4B",
            "KI-RAS",
            "KRAS1",
            "KRAS2",
            "NS",
            "NS3",
            "OES",
            "RALD",
            "RASK2"
        ]
    },
    "variant": "Q61L",
    "createDate": "09/25/2014",
    "updateDate": "02/24/2020",
    "referenceTranscriptCoordinates": {
        "id": 157374,
        "transcript": "NM_033360",
        "gDna": "chr12:g.25227342T>A",
        "cDna": "c.182A>T",
        "protein": "p.Q61L",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16002,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, RMC-4550 did not inhibit growth of colon cancer cells harboring KRAS Q61L in 3D culture (PMID: 30104724).",
            "molecularProfile": {
                "id": 1863,
                "profileName": "KRAS Q61L"
            },
            "therapy": {
                "id": 7839,
                "therapyName": "RMC-4550",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 14089,
                    "pubMedId": 30104724,
                    "title": "RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30104724"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8566,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Sapanisertib (MLN0128) and PD-0325901 synergistically inhibited Erk and PI3K signaling and proliferation, but did not induce apoptosis in colorectal cancer cells harboring KRAS Q61L, PIK3CA E542K, and TP53 T118Qfs*5 in culture (PMID: 26272063).",
            "molecularProfile": {
                "id": 26412,
                "profileName": "KRAS Q61L PIK3CA E542K TP53 T118Qfs*5"
            },
            "therapy": {
                "id": 4771,
                "therapyName": "PD-0325901 + Sapanisertib",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6689,
                    "pubMedId": 26272063,
                    "title": "MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26272063"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1863,
            "profileName": "KRAS Q61L",
            "profileTreatmentApproaches": [
                {
                    "id": 15920,
                    "name": "AZD4785",
                    "profileName": "KRAS Q61L"
                },
                {
                    "id": 15919,
                    "name": "MEK2 Inhibitor",
                    "profileName": "KRAS Q61L"
                },
                {
                    "id": 15921,
                    "name": "RAS Inhibitor (Pan)",
                    "profileName": "KRAS Q61L"
                },
                {
                    "id": 15918,
                    "name": "MEK inhibitor (Pan)",
                    "profileName": "KRAS Q61L"
                },
                {
                    "id": 15922,
                    "name": "MEK1 Inhibitor",
                    "profileName": "KRAS Q61L"
                },
                {
                    "id": 15924,
                    "name": "PIK3CA inhibitor",
                    "profileName": "KRAS Q61L"
                },
                {
                    "id": 15923,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "KRAS Q61L"
                }
            ]
        },
        {
            "id": 26355,
            "profileName": "KRAS Q61L PIK3CA E542K",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 26412,
            "profileName": "KRAS Q61L PIK3CA E542K TP53 T118Qfs*5",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 157377,
            "transcript": "XM_006719069",
            "gDna": "chr12:g.25227342T>A",
            "cDna": "c.182A>T",
            "protein": "p.Q61L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 157376,
            "transcript": "XM_011520653",
            "gDna": "chr12:g.25227342T>A",
            "cDna": "c.182A>T",
            "protein": "p.Q61L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 157375,
            "transcript": "XM_017019293",
            "gDna": "chr12:g.25227342T>A",
            "cDna": "c.182A>T",
            "protein": "p.Q61L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 157374,
            "transcript": "NM_033360",
            "gDna": "chr12:g.25227342T>A",
            "cDna": "c.182A>T",
            "protein": "p.Q61L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 157373,
            "transcript": "NM_004985",
            "gDna": "chr12:g.25227342T>A",
            "cDna": "c.182A>T",
            "protein": "p.Q61L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}